|
- Types of COVID-19 Treatment | COVID-19 | CDC
The Infectious Diseases Society of America provides Guidelines on the Treatment and Management of Patients with COVID-19 for healthcare providers to help them work with their patients and determine the best treatment options for their patients
- Coronavirus Disease 2019 (COVID-19) | COVID-19 | CDC
COVID-19 (coronavirus disease 2019) is a disease caused by a virus named SARS-CoV-2 It can be very contagious and spreads quickly
- Symptoms of COVID-19 | COVID-19 | CDC
People with COVID-19 have a wide range of symptoms ranging from mild symptoms to severe illness Symptoms may appear 2-14 days after exposure to the virus Symptoms may start as mild, and some people will progress to more severe symptoms The following list does not include all possible symptoms
- Treating COVID-19 at home: Care tips for you and others
Whether you're caring for yourself or someone else at home, here is some basic information on emergency care, how to stop the spread of the COVID-19 virus and when you can get back to being with others
- Clinical Course: Progression, Management, and Treatment | COVID-19 | CDC
COVID-19 can vary from asymptomatic infection to critical illness Symptoms and severity can change during illness Information about clinical management and treatment of COVID-19 is categorized by severity of illness
- Patient education: COVID-19 overview (The Basics) - UpToDate
Patients must speak with a health care provider for complete information about their health, medical questions, and treatment options, including any risks or benefits regarding use of medications
- Clinical Considerations for Special Populations | COVID-19 | CDC
Recommendations on who should be considered for CP and clinical information on treating patients with CP who have immunocompromising conditions, can be found in the Infectious Diseases Society of America (IDSA) Guidelines on the Treatment and Management of Patients with COVID-19
- COVID-19 Treatment Clinical Care for Outpatients
Clinicians should consider COVID-19 treatment in patients with mild or moderate COVID-19 who have one or more risk factors for severe COVID-19 to reduce progression to hospitalization and death Treatment must be started as soon as possible and within 5-7 days of symptom onset
|
|
|